Category Archives: OTC



Jun 23, 2017

OTC Disclosure News Service

Surrey, BC, Canada

This release includes additional documents. Select the link(s) below to view.

LMR NR FT and HD PrivatePlacement 06-23-2017.pdf

Copyright © 2017 OTC Markets. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Article source:

Zoompass Holdings, Inc. (ZPAS: OTC Pink Current) | IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Zoompass Holdings, Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, Calif., June 23, 2017 (GLOBE NEWSWIRE) — Khang Khang LLP (the “Firm”) announces a securities class action lawsuit against Zoompass Holdings, Inc. (“Zoompass” or the “Company”) (Other OTC: ZPAS). Investors who purchased or otherwise acquired shares from April 24, 2017 through May 24, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the July 31, 2017 lead plaintiff motion deadline.

If you purchased Zoompass shares during the Class Period, please contact Joon M. Khang, Esq., of Khang Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the Complaint, throughout the Class Period, Zoompass made false and/or misleading statements and/or failed to disclose: that the Company unlawfully engaged in a scheme to promote its stock; that the discovery of the foregoing conduct would subject Zoompass to heightened regulatory scrutiny and potential criminal sanctions; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. On May 9, 2017, Zoompass revealed that it had been “made aware of and requested by the OTC Markets Group, Inc. to comment on recent trading and potential promotional activity.” On May 25, 2017, Seeking Alpha reported that Zoompass had erroneously denied its involvement with a scheme designed to promote its stock and purposely conceal that the Company’s CEO was involved in a pump-and-dump scheme. When this news was announced, Zoompass shares decreased in value, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at

This press release may constitute Attorney Advertising in some jurisdictions.


Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474

Primary Logo

Article source:

Reliq Health Technologies Inc. (RQHTF: OTCQB) | Reliq Health Provides Corporate Update

VANCOUVER, BRITISH COLUMBIA–(Marketwired – June 23, 2017) – Reliq Health Technologies Inc. (TSX VENTURE:RHT)(OTCQB:RQHTF) (“Reliq” or the “Company“), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announced that further to its news release dated June 9, 2017 and June 22, 2017, the Company has received final TSX Venture Exchange approval on the non-brokered private placement of 6,937,200 Units (the “Units“) of the Company at a price of $0.11 per Unit for gross proceeds of $763,092.00.

Each Unit each consists of one (1) common share (the “Common Share“) and one half (1/2) transferrable share purchase warrant (the “Warrant“). Each of the 3,468,600 warrants entitles the holder thereof to purchase one (1) additional Common Share.

The subscribers to the private placement agreed to a voluntary 6 month hold period on securities issued. 

Total Pro Group involvement for 4,546,200 Units in the amount of $500,000.00 was subscribed for by one individual.


Dr. Lisa Crossley, CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. 

Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

Article source:

Bunk Beds